Drug shows promise in 1st largely minority COVID-19 study
The drug, via an IV, tamps down a protein called interleukin-6 that's often found in excess in COVID-19 patients.
More from Oklahoma Religion
Baptist Messenger Oklahoma
Hearings for candidate challenges rescheduled for Feb. 22
Oklahoma Religion
•
Feb 18, 2021
Baptist Messenger Oklahoma
Washee-Gutierrez continues generational beading passion
Oklahoma Religion
•
Feb 16, 2021
Baptist Messenger Oklahoma
Fresh funding aims to revitalize Indigenous oral history
Oklahoma Religion
•
Feb 15, 2021
Baptist Messenger Oklahoma
Rare Disease Day acknowledged on Feb. 28
Oklahoma Religion
•
Feb 14, 2021
Baptist Messenger Oklahoma
Judge blocks another bid to shut down Line 3 construction
Oklahoma Religion
•
Feb 14, 2021
Baptist Messenger Oklahoma
Senate panel advances EPA nominee; GOP slams Interior pick
Oklahoma Religion
•
Feb 14, 2021
Baptist Messenger Oklahoma
StrongHearts Native Helpline launches 24/7 operations, text advocacy
Oklahoma Religion
•
Feb 14, 2021